Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Symbicort Turbuhaler 30/60 Clinical Experience Investigation for Treatment With Symbicort as Maintenance Therapy and as Needed in Response to Symptoms

NCT01711840 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01711840
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01711840 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Symbicort Turbuhaler 30/60 Clinical Experience Investigation for Treatment With Symbicort as Maintenance Therapy and as Needed in Response to Symptoms
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
August 31, 2015
Enrollment
2,409 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma